Neugenesis Corporation

Biotechnology ResearchCalifornia, United States11-50 Employees

Neugenesis Corporation is focused on generating better biotherapeutics, cost-effectively. To this end, Neugenesis has developed technology that has substantial value in the discovery, improvement and production of complex proteins; especially heteromeric proteins. The Company's work with the filamentous fungi Neurospora crassa has resulted in significant advances in three important areas of biotechnology: directed evolution, combinatorial biology and recombinant protein expression.

Neugenesis was acquired by Intrexon Corporation in April, 2011.

Sign up for free to view info

Email Format Employee directory